Kell and Kx blood group systems

Immunohematology

Volumn 31, Issue 1, 2015, Pages 14-19

  Denomme, Gregory A ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

Blood group systems; Kell; Kx

Indexed keywords

ALLOANTIBODY; ANTIGEN; KELL GLYCOPROTEIN; KX ANTIGEN; UNCLASSIFIED DRUG; XK PROTEIN; BLOOD GROUP ANTIBODY; BLOOD GROUP ANTIGEN; AMINO ACID TRANSPORTER; KEL PROTEIN, HUMAN; MEMBRANE PROTEIN; METALLOPROTEINASE; XK PROTEIN, HUMAN;

ANEMIA; BLOOD GROUP KELL SYSTEM; BLOOD GROUP KX SYSTEM; BLOOD GROUP SYSTEM; BLOOD TRANSFUSION REACTION; ERYTHROCYTE; ERYTHROPOIESIS; HEMOLYTIC ANEMIA; HUMAN; IMMUNOGENICITY; INFANT; MCLEOD SYNDROME; NEWBORN; PRIORITY JOURNAL; RETICULOCYTOPENIA; REVIEW; ALLOIMMUNIZATION; IMMUNOHISTOCHEMISTRY; KX BLOOD GROUP SYSTEM; OLIGONUCLEOTIDE PROBE; TRANSFUSION MEDICINE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MUTATION; NEUROACANTHOCYTOSIS; NEWBORN HEMOLYTIC DISEASE; PREGNANCY;

AMINO ACID TRANSPORT SYSTEMS, NEUTRAL; ERYTHROBLASTOSIS, FETAL; ERYTHROCYTES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; METALLOENDOPEPTIDASES; MUTATION; NEUROACANTHOCYTOSIS; PREGNANCY;

EID: 84946397106     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Lee S, Zambas ED, Marsh WL, Redman CM. Molecular cloning and primary structure of Kell blood group protein. Proc Natl Acad Sci U S A 1991;88:6353-7.
2. Table of blood group antigens within systems. http://www.isbtweb.org/fileadmin/user_upload/files-2015/red%20cells/links%20tables%20in%20introduction%20text/Table%20blood%20group%20antigens%20within%20systems%20v4.0%20141124.pdf. Accessed 25 June 2015.
3. Coombs RR, Mourant AE, Race RR. In-vivo isosensitisation of red cells in babies with haemolytic disease. Lancet 1946;1: 264-6.
4. Levine P, Backer M, Wigod M, Ponder R. A new human hereditary blood property (Cellano) present in 99.8% of all bloods. Science 1949;109:464-6.
5. Lee S, Russo D, Redman CM. The Kell blood group system: Kell and XK membrane proteins. Semin Hematol. 2000;37:113-21.
6. Redman CM, Lee S. A historical perspective on the discovery of the Kell blood group carriers. Transfusion 2013;53: 2831-3.
7. Camara-Clayette V, Rahuel C, Lopez C, et al. Transcriptional regulation of the KEL gene and Kell protein expression in erythroid and non-erythroid cells. Biochem J 2001;356: 171-80.
8. Rojewski MT, Schrezenmeier H, Flegel WA. Tissue distribution of blood group membrane proteins beyond red cells: evidence from cDNA libraries. Transfus Apher Sci 2006;35:71-82.
9. Russo D, Wu X, Redman CM, Lee S. Expression of Kell blood group protein in nonerythroid tissues. Blood 2000;96:340-6.
10. Lee S, Lin M, Mele A, et al. Proteolytic processing of big endothelin-3 by the Kell blood group protein. Blood 1999; 94:1440-50.
11. Anstee DJ, Ridgwell K, Tanner MJ, Daniels GL, Parsons SF. Individuals lacking the Gerbich blood-group antigen have alterations in the human erythrocyte membrane sialoglycoproteins beta and gamma. Biochem J 1984;221: 97-104.
12. Ho M, Chelly J, Carter N, Danek A, Crocker P, Monaco AP. Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein. Cell 1994;77:869-80.
13. De Franceschi L, Bosman GJ, Mohandas N. Abnormal red cell features associated with hereditary neurodegenerative disorders: the neuroacanthocytosis syndromes. Curr Opin Hematol 2014;21:201-9.
14. Lee S. The value of DNA analysis for antigens of the Kell and Kx blood group systems. Transfusion 2007;47:32S-39S.
15. Allen FH Jr, Lewis SJ. Kpa (Penney), a new antigen in the Kell blood group system. Vox Sang 1957;2:81-7.
16. Yazdanbakhsh K, Lee S, Yu Q, Reid ME. Identification of a defect in the intracellular trafficking of a Kell blood group variant. Blood 1999;94:310-8.
17. Kormoczi GF, Scharberg EA, Gassner C. A novel KEL*1,3 allele with weak Kell antigen expression confirming the cis-modifier effect of KEL3. Transfusion 2009;49:733-9.
18. Bosco A, Xenocostas A, Kinney J, Cadwell CM, Zimring JC. An autoanti-Kp b immunoglobulin M that simulates antigen suppression. Transfusion 2009;49:750-6.
19. Seyfried H, Gorska B, Maj S, Sylwestrowicz T, Giles CM, Goldsmith KL. Apparent depression of antigens of the Kell blood group system associated with autoimmune acquired haemolytic anaemia. Vox Sang 1972;23:528-36.
20. Danek A, Rubio JP, Rampoldi L, et al. McLeod neuroacan-thocytosis: genotype and phenotype. Ann Neurol 2001;50: 755-64.
21. Lee S, Zambas E, Green ED, Redman C. Organization of the gene encoding the human Kell blood group protein. Blood 1995;85:1364-70.
22. Zelinski T, Coghlan G, Myal Y, et al. Genetic linkage between the Kell blood group system and prolactin-inducible protein loci: provisional assignment of KEL to chromosome 7. Ann Hum Genet 1991;55:137-40.
23. Lee S, Debnath AK, Redman CM. Active amino acids of the Kell blood group protein and model of the ectodomain based on the structure of neutral endopeptidase 24.11. Blood 2003;102:3028-34.
24. Lee S, Wu X, Reid M, Redman C. Molecular basis of the K:6,-7 [Js(a+b-)] phenotype in the Kell blood group system. Transfusion 1995;35:822-5.
25. Lee S, Wu X, Reid M, Zelinski T, Redman C. Molecular basis of the Kell (K1) phenotype. Blood 1995;85:912-6.
26. Lee S, Wu X, Son S, et al. Point mutations characterize KEL10, the KEL3, KEL4, and KEL21 alleles, and the KEL17 and KEL11 alleles. Transfusion 1996;36:490-4.
27. Yu LC, Twu YC, Chang CY, Lin M. Molecular basis of the Kell-null phenotype: a mutation at the splice site of human KEL gene abolishes the expression of Kell blood group antigens. J Biol Chem 2001;276:10247-52.
28. Names for Kell (ISBT 006) Blood Group Alleles. http://www.isbtweb.org/fileadmin/user_upload/files-2015/red%20cells/blood%20group%20allele%20terminology/allele%20tables/006%20KEL%20Alleles%20v3.0%20131028.pdf. Accessed 25 June 2015.
29. Lee S, Russo DC, Reid ME, Redman CM. Mutations that diminish expression of Kell surface protein and lead to the Kmod RBC phenotype. Transfusion 2003;43:1121-5.
30. Tormey CA, Stack G. Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy-related antibodies. Blood 2009;114:4279-82.
31. Tormey CA, Stack G. The persistence and evanescence of blood group alloantibodies in men. Transfusion 2009;49:505-12.
32. Moise KJ. Fetal anemia due to non-Rhesus-D red-cell alloimmunization. Semin Fetal Neonatal Med 2008;13: 207-14.
33. Chiaroni J, Dettori I, Ferrera V, et al. HLA-DRB1 polymorphism is associated with Kell immunisation. Br J Haematol 2006;132:374-8.
34. WesthoffCM, Reid ME. Review: the Kell, Duffy, and Kidd blood group systems. Immunohematology 2004;20:37-49.
35. Bansal I, Jeon HR, Hui SR, et al. Transfusion support for a patient with McLeod phenotype without chronic granulomatous disease and with antibodies to Kx and Km. Vox Sang 2008;94:216-20.
36. Russo DC, Oyen R, Powell VI, et al. First example of anti-Kx in a person with the McLeod phenotype and without chronic granulomatous disease. Transfusion 2000;40:1371-5.
37. Vaughan JI, Warwick R, Letsky E, Nicolini U, Rodeck CH, Fisk NM. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol 1994;171:247-52.
38. Bowman JM, Pollock JM, Manning FA, Harman CR, Menticoglou S. Maternal Kell blood group alloimmunization. Obstet Gynecol 1992;79:239-44.
39. Moise KJ Jr, Argoti PS. Management and prevention of red cell alloimmunization in pregnancy: a systematic review. Obstet Gynecol 2012;120:1132-9.
40. Bony V, Gane P, Bailly P, Cartron JP. Time-course expression of polypeptides carrying blood group antigens during human erythroid differentiation. Br J Haematol 1999;107:263-74.
41. Daniels G, Hadley A, Green CA. Causes of fetal anemia in hemolytic disease due to anti-K. Transfusion 2003;43:115-6.
42. Vaughan JI, Manning M, Warwick RM, Letsky EA, Murray NA, Roberts IA. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998;338:798-803.
43. Grant SR, Kilby MD, Meer L, Weaver JB, Gabra GS, Whittle MJ. The outcome of pregnancy in Kell alloimmunisation. BJOG 2000;107:481-5.
44. Stephen J, Cairns LS, Pickford WJ, Vickers MA, Urbaniak SJ, Barker RN. Identification, immunomodulatory activity, and immunogenicity of the major helper T-cell epitope on the K blood group antigen. Blood 2012;119:5563-74.